Behrens, Frank
Tony, Hans-Peter
Koehm, Michaela
Schwaneck, Eva C.
Gnann, Holger
Greger, Gerd
Burkhardt, Harald
Schmalzing, Marc http://orcid.org/0000-0002-3289-2299
Funding for this research was provided by:
AbbVie Deutschland (None)
Article History
Received: 25 October 2019
Revised: 28 February 2020
Accepted: 5 March 2020
First Online: 23 March 2020
Change Date: 30 May 2020
Change Type: Correction
Change Details: The original version of this article was published without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed.]
Compliance with ethical standards
:
: FB, H-PT, MK, ECS, HB, and MS have served as consultants to AbbVie Deutschland GmbH & Co. KG and have received research funding, speaker fees, or compensation for consultation from AbbVie. HG is a paid consultant for AbbVie. GG is a former employee of AbbVie and may own AbbVie stock.
: This study was approved by the appropriate ethics committee and was performed in accordance with ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Ethics approval was obtained from the Ethics Commission of the Medical Department of Goethe University, Frankfurt am Main, Germany (number 122/09). All patients were informed of the objectives of the observational study and gave written consent for their voluntary participation in the study and the anonymous use of personal data in statistical analyses.